Download Literatuur en referenties

Longcarcinomen
7.9.9.
Longcarcinoom:
Literatuur en referenties
1. Niet-invasieve stadiëring longcarcinoom
-
American Thoracic Society (ATS), European Respiratory Society (ERS). Pretreatment
evaluation of non-small cell lung cancer. Am J Respir Crit Care Med 1997; 156:320-332.
-
Micke P, Faldum A, Metz T, et al. Staging small cell lung cancer: Veterans Administration
Lung Study Group versus International Association for the Study of Lung Cancer - what
limits limited disease? Lung Cancer 2002; 37:271-276.
-
Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;
111:1710-1717.
-
Pfister DG, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology
treatment of unresectable non-small cell lung cancer guideline: update 2003. J Clin Oncol
2004; 22:330-353.
-
Postmus PE, Rocmans P, Asamura H, et al. IASLC consensus report: pretreatment
minimal staging for non-small cell lung cancer. Lung Cancer 2003; 42 Suppl 1:3S-6S.
-
Silvestri GA, Tanoue LT, Margolis ML, Barker J, Detterbeck F. The noninvasive staging of
non-small cell lung cancer: The guidelines. Chest 2003; 123 Suppl 1:147S-156S.
-
Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004;
350:379-392.
-
Spiro SG, Porter JC. Lung cancer-where are we today? Current advances in staging and
non-surgical treatment. Am J Respir Crit Care Med 2002; 166:1166-1196.
-
Stahel RA, Ginsberg R, Havemann K, et al. Staging and prognostic factors in small cell
lung cancer: a consensus. Lung Cancer 1989; 5:119-126.
-
Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: A
review of the current evidence. Chest 2003; 123 Suppl 1:137S-146S.
-
Vansteenkiste JF, Stroobants SG, De Leyn PR, et al. Lymph node staging in non-small
cell lung cancer with FDG-PET scan: A prospective study on 690 lymph node stations
from 68 patients. J Clin Oncol 1998; 16:2142-2149.
2. Invasieve locoregionale stadiëring van longcarcinoom
-
Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging.
Chest 1997; 111:1718-1723.
-
Toloza EM, Harpole L, Detterbeck F, McCrory DC. Invasive staging of non-small cell lung
cancer: a review of the current evidence. Chest 2003; 123 Suppl 1:157S-166S.
Hfdst. 7.9.9. - 1.
Longcarcinomen
3. Preoperatieve functionele evaluatie
-
ATS/ERS statement: Pretreatment evaluation of NSCLC. Am J Respir Crit Care Med ’97.
Vol 156, p 320-332.
-
Medical evaluation of the patient with potentially respectable lung cancer. Lung cancer:
Principles and practice, 1996. Chapter 31: p 511-534.
-
Guidelines on the selection of patients with lung cancer for surgery. Thorax 2001; 56: 89108.
-
Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: an abridged
version of the report of the American College of Cardiology/American Heart Association
task forse on practical guidelines. Eagle et al, Mayo Clin Proc 1997; 72: 524-531.
4. Behandeling van vroege stadia Niet Kleincellig Longcarcinoma (NKCLC)
-
Blum RH. Adjuvant chemotherapy for lung cancer - a new standard of care. N Engl J Med
2004; 350:404-405.
-
Bradley JD, Wahab S, Lockett MA, Perez CA, Purdy JA. Elective nodal failures are
uncommon in medically inoperable patients with stage I non-small cell lung carcinoma
treated with limited radiotherapy fields. Int J Radiat Oncol Biol Phys 2003; 56:342-347.
-
Gauden S, Ramsay J, Tripcony L. The curative treatment by radiotherapy alone of stage I
non-small cell carcinoma of the lung. Chest 1995; 108:1278-1282.
-
Smythe WR. Treatment of stage I non-small cell lung carcinoma. Chest 2003; 123 Suppl
1:181S-187S.
-
Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004;
350:379-392.
-
The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based
adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N
Engl J Med 2004; 350:351-360.
5. Behandeling van potentieel resecabel stadium III NKCLC
-
Andre F, Grunenwald D, Pignon JP, et al. Survival of patients with resected N2 non-smallcell lung cancer: evidence for a subclassification and implications. J Clin Oncol
2000;18:2981-2989.
-
Bueno R, Richards WG, Swanson SJ, et al. Nodal stage after induction therapy for stage
IIIA lung cancer determines patient survival. Ann Thorac Surg 2000; 70:1826-1831.
-
De Leyn P. Schoonhooghe P, Deneffe G, et al. Surgery for non-small cell lung cancer with
unsuspected metastasis to ipsilateral mediastinal or subcarinal nodes (N2 disease). Eur J
Cardiothorac Surg 1996; 10:649-655.
-
Depierre A, Milleron B, Moro-Sibilot D, et al. Preoperative chemotherapy followed by
surgery compared with primary surgery in resectable stage I, II, and IIIA non-small-cell
lung cancer. J. Clin Oncol 2001;20:247-253.
-
Detterbeck FC. Diagnosis and treatment of lung cancer. An evidence-based guide for the
practicing clinician. W.B. Saunders company 2001. ISBN 0-7216-9192-7.
Hfdst. 7.9.9. - 2.
Longcarcinomen
-
Fernando HC, Goldstraw P. The accuracy of clinical intrathoracic staging as assessed by
postsurgical pathological stage. Cancer 1990; 65:2503-2506.
-
Funatsu T, Matsubaru Y, Hatakenaka R, et al. The role of mediastinoscopic biopsy in
preoperative assessment of lung cancer. J Thorac Cardiovasc Surg 2002; 104: 1688-1695.
-
Lorent N, De Leyn P, Lievens Y, et al. Long-term survival of surgically staged IIIA-N2 nonsmall cell lung cancer treated with surgical combined modality approach: analysis of a 7year experience. Ann Oncol 2004; 15:1645-1653.
-
Martini N, Yellin A, Ginsberg RJ, et al. Management of non-small-cell lung cancer with
direct mediastinal involvement. Ann Thorac Surg 1994;58:1447-1451.
-
Pearson FG, Delarue NC, Ilves R, et al. Significance of positive superior mediastinal nodes
identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac
Cardiovasc Surg 1982; 83:1-11.
-
PORT meta-analysis Trialists Group. Postoperative Radiotherapy in non-small-cell lung
cancer. Systematic review and meta-analysis of individual patient data from nine
randomised controlled trials. Lancet 1998; 352:257-263.
-
Robinson L, Wagner H, Ruckdeschel JC. Treatment of stage IIIA non-small cell lung
cancer. Chest 2003; 123:202S-220S.
-
Rosell R, Gomez-Codina J, Camps C, et al. Preresectional chemotherapy in stage IIIA
non-small cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung
Cancer 1999;47:7-14.
-
Roth JA, Atkinson EN, Fossella F, et al. Long-term follow-up of patients enrolled in a
randomized trial comparing perioperative chemotherapy and surgery with surgery alone in
resectable stage IIIA non-small cell lung cancer. Lung Cancer 1998;21:1-6.
-
Rusch VW, Giroux DJ, Kraut MJ, et al. et al. Induction chemoradiation and surgical
resection for non-small cell lung carcinomas of the superior sulcus: initial results of
Southwest Oncology Group Trial 9416 (Intergroup trial 0160). J Thorac Cardiovasc Surg
2001; 121:472-483.
6. Behandeling gevorderde stadia Niet Kleincellig Longcarcinoma (NKCLC)
7. Behandeling “Limited Disease” Kleincellig Longcarcinoma (KCLC)
-
Aupérin A, Arriagada R, Pignon J-P, et al. Prophylactic cranial irradiation for patients with
small cell lung cancer in complete remission. N Engl J Med 1999; 341: 476-484.
-
Choi NC, Carey R. Importance of radiation dose in achieving improved loco-regional
tumor control in limited stage small cell lung carcinoma: an update. Int J Radiat Oncol Biol
Phys 1989; 17:307-310.
-
Coolen L, Vanden Eeckhout A, Deneffe G, Demedts M, Vansteenkiste J. Surgical
treatment of small cell lung cancer. Eur J Cardiothorac Surg 1995; 9:59-64.
-
Chrystal K, Cheong K, Harper P. Chemotherapy of small cell lung cancer: state of the art.
Curr Opin Oncol 2004; 16:136-140.
-
De Ruysscher D, Vansteenkiste J. Chest radiotherapy in limited stage small cell lung
cancer: Facts, questions, prospects. Radiother Oncol 2000; 55:1-9.
Hfdst. 7.9.9. - 3.
Longcarcinomen
-
Gregor A, Drings P, Burghouts J, et al. Randomized trial of alternating versus sequential
radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a
European Organization for Research and Treatment of Cancer Lung Cancer Cooperative
Group Study. J Clin Oncol 1997; 15:2840-2849.
-
Inoue M, Miyoshi S, Yasumitsu T, et al. Surgical results for SCLC based on the new TNM
staging system. Ann Thorac Surg 2000; 70: 1615-1619.
-
Komaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with
limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation.
Int J Radiat Oncol Biol Phys 1995; 33:179-182.
-
Laurie SA, Logan D, Markman BR, Mackay JA, Evans WK. Practice guideline for the role
of combination chemotherapy in the initial management of limited-stage small cell lung
cancer. Lung Cancer 2004; 43:223-240.
-
Murray N, Coy, Pater JL, et al. Importance of timing for thoracic irradiation in the
combined modality treatment of limited-stage small cell lung cancer. J Clin Oncol. 1993;
11: 336-44.
-
Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for smallcell lung cancer. N Eng J Med. 1992; 327: 1618-1624
-
Stahel RA, Ginsberg R, Havemann K, et al. Staging and prognostic factors in small cell
lung cancer: a consensus. Lung Cancer 1989; 5:119-126.
-
Szczesny TJ, Szczesna A, Shepherd FA, Ginsberg RJ. Surgical treatment of small cell
lung cancer. Semin Oncol 2003; 30:47-56.
-
Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential
thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small
cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol
2002; 20: 3054-3060.
-
Turrisi AT, Kim K, Blum R, et al. Twice daily compared with once-daily thoracic
radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and
etoposide.N Eng J Med 1999:340: 265-271.
-
Van Oosterhout AG, Van de Pol M, Ten Velde GP, Twijnstra A. Neurologic disorders in
203 consecutive patients with small cell lung cancer. Results of a longitudinal study.
Cancer 1996; 77:1434-1441.
8. Behandeling “Extensive Disease” Kleincellig Longcarcinoma (KCLC)
-
Chua YJ, Steer C, Yip D. et al. Recent advances in management of small cell lung cancer.
Cancer Treat Rev 2004; 30: 521-543.
-
Girling DJ. Comparison of oral etoposide and standard intravenous multi-drug
chemotherapy for small-cell lung cancer: a stopped multi-centre randomised trial. Medical
Research Council Lung Cancer Working Party. Lancet 1996; 348:563-566.
-
Huisman C, Postmus PE, Giaccone G, et al. Second-line chemotherapy and its evaluation
in small cell lung cancer. Cancer Treat Rev 1999; 25:199-206.
-
Johnson BE, Fischer T, Fischer B, et al. Phase II study of Imatinib in patients with small
cell lung cancer. Clin Cancer Res 2003; 9:5880-5887.
Hfdst. 7.9.9. - 4.
Longcarcinomen
-
Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with
etoposide plus cisplatin for extensive small cell lung cancer. N Engl J Med 2002; 346:8591.
-
Pujol JL, Carestia L, Daures JP. Is there a case for cisplatin in the treatment of small cell
lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus
a regimen without this alkylating agent. Br J Cancer 2000; 83:8-15.
-
Sculier JP, Berghmans T, Castaigne C, et al. Maintenance chemotherapy for small cell
lung cancer: a critical review of the literature. Lung Cancer 1998; 19:141-151.
-
Shepherd FA, Giaccone G, Seymour L, et al. Prospective, randomized, double-blind,
placebo-controlled trial of marimastat after response to first-line chemotherapy in patients
with small cell lung cancer. J Clin Oncol 2002; 20:4434-4439.
-
Tebbutt NC, Snyder RD, Burns WI. An analysis of the outcomes of treatment of small cell
lung cancer in the elderly. Aust NZ J Med 1997; 27: 160-164.
-
Von Pawel J, Schiller JH, Shepherd FA, et al. Topotecan versus cyclophosphamide,
doxorubicin, and vincristine for the treatment of recurrent small cell lung cancer. J Clin
Oncol 1999; 17:658-667.
-
Yip D, Harper PG. Predictive and prognostic factors in small cell lung cancer: current
status. Lung Cancer 2000; 28: 173-185.
Hfdst. 7.9.9. - 5.